PwC's Health Research Institute Identifies the Top Ten Health Industry Issues to Watch in 2013

1.

States on the frontlines of Affordable Care Act implementation
Over the next year, state officials must decide how to run insurance exchanges, whether to expand Medicaid coverage, and what type of insurance market regulation is needed. The biggest challenge states may face in 2013 will be information technology. Designing infrastructure to create a single, seamless entry point to the exchange will require some states to undergo a major overhaul of existing Medicaid eligibility systems.

2.

Consumer revolution in health coverage
Consumers' rising voice on how they spend their healthcare dollars, coupled with state insurance exchanges, is prompting the health industry to compete on attributes similar to the retail industry: convenience, price and transparency.  HRI found signs that consumers already are warming up to new ways of purchasing insurance: nearly one-quarter (23 percent) of consumers surveyed said they are likely to buy health insurance from non-traditional sources such as a retail store, up from 18 percent in 2011.

3.

Medtech industry braces for excise tax impact
A 2.3 percent excise tax on medical device companies takes effect on January 1, 2013, representing potentially $29.1 billion to the federal government over the next 10 years. The $380 billion global medical device industry is unlikely to be able to pass the tax on to its customers, but could look to its suppliers to share in the burden.  Some companies could owe more in taxes than they generate in profits, making them less attractive to investors but more enticing to larger companies looking to expand their portfolio.  The tax impact should kick start new innovation, industry consolidation and operational recalibration in the medtech sector.

4.

Caring for the nation's most vulnerable: dual eligibles
Dual eligibles – people who qualify for both Medicare and Medicaid – make up many of the 16 million people the ACA will add to Medicaid rolls by 2019.  The cost of care for duals is skyrocketing – much of it wasted due to a lack of care coordination between the two programs – and 70 percent of state Medicaid spending on duals goes to long-term care support services, such as nursing homes.  Cash-strapped states are increasingly turning to the expertise of managed care companies to better coordinate care, and they are seeking innovative solutions, such as from the technology sector, to better support home-based care and caregivers.

5.

Bring your own mobile device: convenience at a cost
Doctors and nurses are bringing their own mobile devices to work, but many hospitals do not yet have a secure enough environment to protect sensitive patient information.  Sixty-nine percent of consumers surveyed said they are concerned about the privacy of their medical information if providers were able to access it on their mobile devices.  According to PwC, only 46 percent of hospitals have a security strategy to regulate the use of mobile devices.

6.

Goodbye cost reduction, hello transformation
With reimbursement resetting under the ACA and pressure from the federal budget crisis and price-conscious consumers, hospitals are scrambling to further reduce their costs.  HRI research found that 40 percent of consumers postponed care in 2012 because of the costs.  Having already plucked low-hanging fruit with labor productivity and supply cost reductions, more hospitals in 2013 will embark on full-scale transformation efforts to redesign how they deliver care.

7.

Customer ratings hit the pocketbooks of healthcare companies
Paying for performance will take on new meaning in 2013 as consumer reviews generate penalties and bonuses for hospitals and insurers. This could mean a bonus payout of more than $3 billion for insurers and a hold back of $850 million for providers in 2013. Healthcare companies will need to invest in consumer research and education in order to take full advantage of the new payments.

8.

Meeting the new expectations of pharma value
Physicians, once the primary arbiters of pharma value, now have less say in payment decisions than insurers and large providers. The final hurdle in the long, expensive path to drug and device development is not regulatory approval, but rather reimbursement.  Though pharmaceutical and medical device companies play a pivotal role in health outcomes, they will have to prove it to earn it by demonstrating their value and comparative effectiveness.

9.

Bigger than benefits: employers rethink their role in healthcare
For nearly 70 years, employer-based coverage has been a cornerstone of U.S. healthcare - but healthcare and employers may not be inseparable.  With the Supreme Court ruling to uphold the ACA and the re-election of the President, employers have an opportunity to re-examine their long term role in providing healthcare coverage and explore alternative approaches provided by state and/or private exchanges.  In 2013, CEOs will ask tough questions about how and why so many resources are going to something that is not core to the business.  The answers will vary by company, some of which are likely to transition away from healthcare coverage while others will redesign their benefit strategies.

10.

The building blocks of population health management
Medicare's accountable care organization and patient-centered medical home initiatives laid a foundation for improving population health, but other collaborations are fueling growth in population health management.  In 2013, more companies are likely to form partnerships to build their population health IT infrastructures and to share responsibility for patient outcomes and satisfaction, data collection and analysis, member education and engagement, with a focus on at-risk populations.